Form 8-K · Current report
Humana 8-K, filed Jul 29, 2026
- Filed
- CIK
- 0000049071
- Accession no.
- 0000049071-26-000045
Summary
Humana reported second-quarter 2026 GAAP diluted EPS of $5.73 and Adjusted EPS of $7.61, and said it affirmed full-year 2026 Adjusted EPS guidance of at least $9.00 while revising GAAP EPS guidance to at least $6.52 from at least $8.36. The company reported a 2Q26 Insurance segment benefit ratio of 91.2%, affirmed full-year 2026 benefit ratio guidance of 92.75% plus or minus 25 basis points, and said it expects individual Medicare Advantage membership growth of approximately 25% over 2025.
Key points
- Humana reported 2Q26 GAAP EPS of $5.73 and Adjusted EPS of $7.61, with YTD 2026 GAAP EPS of $15.55 and Adjusted EPS of $17.91.
- 2Q26 Insurance segment GAAP benefit ratio was 91.2%, and Humana affirmed FY 2026 Insurance segment benefit ratio guidance of 92.75%, plus or minus 25 basis points.
- Humana affirmed FY 2026 Adjusted EPS guidance of at least $9.00 and revised GAAP EPS guidance to at least $6.52 from at least $8.36.
- Humana reported YTD growth of 130,900 patients, or 27%, in CenterWell Senior Primary Care and was awarded a statewide Illinois Medicaid managed care contract expected to go live in January 2027.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. Item 7.01 Regulation FD Disclosure. Humana Inc. (the "Company") issued a press release this morning reporting financial results for the quarter ended June 30, 2026, and posted a detailed earnings release related to the same period to the Investor Relations portion of the Company’s website at www.humana.com. A copy of each release is attached hereto as Exhibit 99.1 and Exhibit 99.2, respectively, and each release is incorporated herein by reference. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.